[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Crockett A, Hollis F
Firstly, it enhances insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning insulin is released only when blood glucose levels are elevated, thereby reducing the risk of hypoglycaemia
Last delivery and so far so good
In the SURMOUNT clinical trial series, participants maintained weight loss for up to 2 years when continuing the medication, losing an average of 2022% of body weight at higher doses
Key findings from this study include (see Figure 2): Prevalence of OLLMM by age increases from 5.1% for age group 20-29, to 12.5% for age group 50-59, 20.2% for age group 60-69, 36.8% for age group 70-79, and 38.7% for age group 80